NPPA fixes retail price of 28 formulations: December 2021

Download the notification:

628
NPPA Price of drugs

Last Updated on December 31, 2021 by The Health Master

Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of twenty eight (28) formulations under the Drugs (Prices Control) Order, 2013, based on the decision of the Authority meeting held on based on the decision of 94th Authority Meeting dated 23.12.2021 vide notification S.O. 5423(E) dated 28-12-2021.

NPPA, in its order on December, 28, listed the twenty eight (28) formulations for which it has fixed retail prices. A list of the formulations has been given below:

Formulations:

Sl. No.Name of the Formulation / Brand NameStrengthUnitManufacturer & Marketing CompanyRetail Price (Rs.)
(1)(2)(3)(4)(5)(6)
1.Cyclosporine Ophthalmic SolutionEach ml contains: Cyclosporine IP 0.9mg Aqueous Buffered Vehicle q.s.Each 0.25ml PackM/s Sun Pharmaceutical Industries Limited51.29
2.    Amoxicillin + Potassium Clavulanate Oral Suspension IPEach 5ml of reconstituted suspension contains: Amoxicillin Trihydrate eq. to Amoxicillin IP 600mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9mg    1 ML    M/s Alkem Healthscience / M/s Alkem Laboratories Ltd.3.36
3.  Povidone- Iodine + Ornidazole OintmentComposition: Povidone-Iodine IP 5%w/w (Available Iodine 0.5%w/w) Ornidazole IP 1% w/w In an Ointment base    1 gmM/s Innova Captab Ltd. / M/s Emcure Pharmaceuticals Ltd.3.78
4.Povidone Iodine Topical SolutionEach 100ml solution contains: Povidone Iodine IP 1.0g (Available Iodine 0.1 g) 2-Propanol IP 50gEach Pack (500ml)M/s GS Pharmabutor Pvt. Ltd. / M/s Win Medicare Pvt. Ltd.230.00
5.          Atorvastatin + Clopidogrel CapsuleEach hard gelatin capsule Contains: Atorvastatin Calcium IP eq to Atorvastatin 40mg (As green coloured spherical pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablets Each containing 37.5mg Clopidogrel Tablets IP)          1 Capsule        M/s Windlas Biotech Limited / M/s Intas Pharmaceuticals Ltd.28.08
6.    Diclofenac Diethylamine + Methyl Salicylate + Menthol GelGel contains: Diclofenac Diethylamine IP 2.32% w/w (equivalent to Diclofenac Sodium IP 2.0% w/w) Methyl Salicylate IP 10% w/w Menthol IP 5% w/w      1 gm    M/s Tuton Pharmaceuticals /M/s Unison Pharmaceuticals Pvt. Ltd.3.69
7.      Telmisartan, Chlorthalidone & Metoprolol (ER) TabletEach film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg        1 Tablet    M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Sun Pharma Laboratories Limited9.86
8.  Telmisartan, Chlorthalidone & Metoprolol (ER) TabletEach film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg      1 TabletM/s Ravenbhel Healthcare Pvt. Ltd. /M/s Sun Pharma Laboratories Limited10.81
9.            Atorvastatin + Clopidogrel + Aspirin CapsuleEach hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As coloured pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablet each containing 37.5mg clopidogrel tablet IP), Aspirin IP 75mg (As enteric coated white coloured pellets)            1 Capsule          M/s Windlas Biotech Limited / M/s Torrent Pharmaceuticals Limited12.92
10.            Atorvastatin + Clopidogrel + Aspirin CapsuleEach hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As coloured pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two reddish brown coloured film coated tablet each containing 37.5mg clopidogrel tablet IP), Aspirin IP 75mg (As enteric coated white coloured pellets)            1 Capsule          M/s Windlas Biotech Pvt. Ltd. / M/s USV Pvt. Ltd.12.92
11.      Telmisartan, Chlorthalidone & Metoprolol (ER) TabletEach film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg        1 Tablet      M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Lupin Limited9.86
12.      Telmisartan, Chlorthalidone & Metoprolol (ER) TabletEach film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg        1 Tablet      M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Lupin Limited10.81
13.      Telmisartan, Chlorthalidone & Metoprolol (ER) TabletEach film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg        1 Tablet      M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Lupin Limited11.92
14.      Telmisartan, Chlorthalidone & Metoprolol (ER) TabletEach film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg        1 Tablet      M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Lupin Limited10.88
15.  Diclofenac injection IPEach ml contains: Diclofenac Sodium IP 75mg Water for injection IP    1 mlM/s Nitin Lifesciences Ltd./ M/s Modi- Mundipharma Pvt. Ltd.20.27
16.  Amoxycillin + Potassium Clavulanate Oral Suspension IPEach 5ml of the reconstituted suspension contains: Amoxycillin Trihydrate eq. to Amoxycillin IP 400mg Potassium Clavulanate Diluted IP eq. to Clovulanic Acid 57mg      1 ml  M/s Associated Biotech./ M/s Eris Healthcare Pvt. Limited3.68
17.  Mefenamic Acid+ Tranexamic Acid TabletEach film coated tablet contains: Mefenamic Acid IP 250mg Tranexamic Acid IP 500mg    1 TabletM/s Pure and Cure Healthcare Pvt. Ltd. / M/s Eris Healthcare Pvt. Limited26.12
18.          Atorvastatin + Clopidogrel CapsuleEach hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As green coloured spherical pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablets Each containing 37.5mg Clopidogrel Tablets IP),          1 Capsule        M/s Windlas Biotech Limited / M/s Torrent Pharmaceuticals Limited28.08
19.Glimepiride + Metformin Hydrochloride + (Sustained Release) + Voglibose TabletEach uncoated bilayer tablet contains : Glimepiride IP – 1 mg Metformin Hydrochloride IP – 500 mg (Sustained Release Form) Voglibose IP – 0.2 mg      1 Tablet    M/s Theon Pharmaceuticals Limited / M/s FDC Limited9.82
20.  Metoprolol Succinate prolonged Released Tablets IPEach film coated prolonged release tablet contains: Metoprolol Succinate IP 95mg eq. to Metoprolol Tartrate 100mg      1 Tablet    M/s Micro Labs Limited11.38
21.Glimepiride + Metformin Hydrochloride + (Sustained Release) + Voglibose TabletEach uncoated bilayer tablet contains : Glimepiride IP – 2 mg Metformin Hydrochloride IP – 500 mg (Sustained Release Form) Voglibose IP – 0.2 mg      1 Tablet    M/s Theon Pharmaceuticals Limited / M/s FDC Limited12.50
22.Clobazam Mouth Dissolving tabletEach uncoated Mouth Dissolving tablet contains: Clobazam IP 2.5mg1 TabletM/s Pure & Cure Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Limited2.54
23.Acetylcysteine + Acebrophylline TabletEach film coated tablet contains: Acetylcysteine BP 600mg Acebrophylline 100mg    1 TabletM/s Pure and Cure Healthcare Pvt. Ltd. / M/ Cipla limited12.48
24.  Levetiracetam Tablet IPEach film coated tablet contains: Levetiracetam IP 1000mg    1 TabletM/s Pure and Cure Healthcare Pvt. Ltd. / M/s Mankind Pharma Ltd.29.87
25.    Levetiracetam Tablet IPEach film coated tablet contains: Levetiracetam IP 1000mg      1 TabletM/s Swiss Garnier Genexiaa Sciences Pvt. Ltd. / M/s Wockhardt Limited26.70
26.  Glycopyrronium + Formoterol Fumarate + Budesonide Powder for InhalationEach capsule contains: Glycopyrrolate IP eq. to Glycopyrronium 25mcg Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 12mcg Budesonide IP 400mcg      1 Capsule      M/s Zydus Healthcare Limited12.64
27.      Esomeprazole + Domperidone SR CapsuleEach hard Gelatin Capsule Contains: Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg (as gastro-resistant pellets) Domperidone IP 30mg (as sustained release pellets)        1 Capsule        M/s Indu Drugs Private Limited10.70
28.  Atorvastatin + Clopidogrel CapsuleEach hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As green coloured spherical pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablets Each containing 37.5mg Clopidogrel Tablets IP),  1 CapsuleM/s Windlas Biotech Limited / M/s Zydus Healthcare Ltd.30.74

(a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

DPCO NPPA

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

Latest notifications – DPCO /NPPA

FAQs – On DPCO: Drugs (Prices Control) Order, 2013


NPPA fixes retail price of 20 formulations: December 2021

NPPA fixes retail price of 2 formulations: November 2021

NPPA fixes retail price of 47 formulations: November 2021

NPPA fixes retail price of 12 Anti Diabetic medicines: October 2021

NPPA fixes retail price of 23 formulations: September 2021

NPPA fixes retail price of 1 formulation: September 2021

NPPA extends price cap on liquid Medical Oxygen and Oxygen inhalation

CDSCO approves Corbevax, Covovax and Molnupiravir for restricted use

Nutraceutical sector concerned over FSSAI’s notification on Marketers

We must learn to live with Covid: WHO

Govt extends implementation date of UDI for Medical Devices

DCGI gives nod to Sun Pharma arm for Molnupiravir in India

USFDA gives nod to Granules India for Prazosin HCL capsules

E-pharmacies, Telemedicine to help cut health expenses

Won’t allow drug peddlers to ruin lives of youth: HM

Latest Notifications regarding Pharmaceuticals


For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner

(c ) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.

(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(F) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.

(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.

(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

Latest notifications – DPCO /NPPA

FAQs – On DPCO: Drugs (Prices Control) Order, 2013


NPPA fixes retail price of 47 formulations: November 2021

NPPA fixes retail price of 12 Anti Diabetic medicines: October 2021

NPPA fixes retail price of 23 formulations: September 2021

NPPA fixes retail price of 1 formulation: September 2021

NPPA extends ceiling price regulation on Orthopaedic knee implants

NPPA extends price cap on LMO and Oxygen inhalation

Procedure to obtain license for Commercial Testing Laboratories

Govt asks States to collaborate with proposed Medical Devices Parks

Morepen gets USFDA nod for anti-allergy drug

Roche develops new research Test Kits for Omicron variant

Booster dose of these 6 Vaccines safe, increases immunity: Study

DGFT notifies norms for Sodium Salicylate & Methylcobalamin

NPPA to hire 33 professionals for various levels of its operations

Govt to amend Drug Rules for list of colours permitted to…

NPPA fixes retail price of 47 formulations: November 2021

Latest Notifications regarding Pharmaceuticals


For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner